ono 1078 has been researched along with Respiratory Distress Syndrome in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizaka, A | 1 |
| Hasegawa, N | 1 |
| Sakamaki, F | 1 |
| Tasaka, S | 1 |
| Nakamura, H | 1 |
| Kishikawa, K | 1 |
| Yamada, A | 1 |
| Obata, T | 1 |
| Sayama, K | 1 |
| Urano, T | 1 |
1 other study available for ono 1078 and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Effects of ONO-1078, a peptide leukotriene antagonist, on endotoxin-induced acute lung injury.
Topics: Albumins; Animals; Bronchoalveolar Lavage Fluid; Chemotaxis, Leukocyte; Chromones; Endotoxins; Esche | 1994 |